The COVID-19 pandemic has shown that bioinformatics--a multidisciplinary field that combines biological knowledge with computer programming concerned with the acquisition, storage, analysis, and dissemination of biological data--has a fundamental role in scientific research strategies in all disciplines involved in fighting the virus and its variants. It aids in sequencing and annotating genomes and their observed mutations; analyzing gene and protein expression; simulation and modeling of DNA, RNA, proteins and biomolecular interactions; and mining of biological literature, among many other critical areas of research. Studies suggest that bioinformatics skills in the Latin American and Caribbean region are relatively incipient, and thus its scientific systems cannot take full advantage of the increasing availability of bioinformatic tools and data. This dataset is a catalog of bioinformatics software for researchers and professionals working in life sciences. It includes more than 300 different tools for varied uses, such as data analysis, visualization, repositories and databases, data storage services, scientific communication, marketplace and collaboration, and lab resource management. Most tools are available as web-based or desktop applications, while others are programming libraries. It also includes 10 suggested entries for other third-party repositories that could be of use.

Subtitle

"Synthetic protein dataset with sequences, physical properties, and functional classification for machine learning tasks."

Description

Introduction

This synthetic dataset was created to explore and develop machine learning models in bioinformatics. It contains 20,000 synthetic proteins, each with an amino acid sequence, calculated physicochemical properties, and a functional classification.

Columns Included

• ID_Protein: Unique identifier for each protein.
• Sequence: String of amino acids.
• Molecular_Weight: Molecular weight calculated from the sequence.
• Isoelectric_Point: Estimated isoelectric point based on the sequence composition.
• Hydrophobicity: Average hydrophobicity calculated from the sequence.
• Total_Charge: Sum of the charges of the amino acids in the sequence.
• Polar_Proportion: Percentage of polar amino acids in the sequence.
• Nonpolar_Proportion: Percentage of nonpolar amino acids in the sequence.
• Sequence_Length: Total number of amino acids in the sequence.
• Class: The functional class of the protein, one of five categories: Enzyme, Transport, Structural, Receptor, Other.

Inspiration and Sources

While this is a simulated dataset, it was inspired by patterns observed in real protein datasets, such as: - UniProt: A comprehensive database of protein sequences and annotations. - Kyte-Doolittle Scale: Calculations of hydrophobicity. - Biopython: A tool for analyzing biological sequences.

Proposed Uses

This dataset is ideal for: - Training classification models for proteins. - Exploratory analysis of physicochemical properties of proteins. - Building machine learning pipelines in bioinformatics.

How This Dataset Was Created

1. Sequence Generation: Amino acid chains were randomly generated with lengths between 50 and 300 residues.
2. Property Calculation: Physicochemical properties were calculated using the Biopython library.
3. Class Assignment: Classes were randomly assigned for classification purposes.

Limitations

• The sequences and properties do not represent real proteins but follow patterns observed in natural proteins.
• The functional classes are simulated and do not correspond to actual biological characteristics.

Data Split

The dataset is divided into two subsets: - Training: 16,000 samples (proteinas_train.csv). - Testing: 4,000 samples (proteinas_test.csv).

Acknowledgment

This dataset was inspired by real bioinformatics challenges and designed to help researchers and developers explore machine learning applications in protein analysis.

Bioinformatics Software Market Outlook

According to our latest research, the global bioinformatics software market size reached USD 11.6 billion in 2024, driven by rapid advancements in genomics and computational biology. The market is forecasted to grow at a robust CAGR of 13.2% from 2025 to 2033, projecting a market value of approximately USD 34.3 billion by the end of 2033. This significant expansion is primarily attributed to the increasing integration of artificial intelligence and machine learning in biological data analysis, as well as the growing adoption of precision medicine and next-generation sequencing technologies across healthcare and research sectors.

A central growth factor for the bioinformatics software market is the exponential rise in biological data generation, particularly through next-generation sequencing (NGS) platforms. As the cost of sequencing continues to decline, laboratories and healthcare providers are generating massive volumes of genomic, transcriptomic, and proteomic data that require sophisticated analysis and interpretation. Bioinformatics software solutions are becoming indispensable for managing, storing, and extracting meaningful insights from this data, enabling breakthroughs in personalized medicine, disease gene identification, and biomarker discovery. Additionally, the increasing collaboration between academic institutions and commercial entities is accelerating the development and deployment of advanced bioinformatics tools, further fueling market growth.

Another pivotal driver is the growing application of bioinformatics in drug discovery and development. Pharmaceutical and biotechnology companies are leveraging bioinformatics software to streamline target identification, optimize lead compounds, and predict drug efficacy and toxicity through in silico modeling. These capabilities significantly reduce the time and cost associated with traditional drug development pipelines, enhancing the productivity of R&D activities. Furthermore, the integration of bioinformatics with clinical diagnostics is enabling more accurate disease diagnosis and prognosis, supporting the trend toward precision healthcare. The expanding use of cloud-based solutions is also democratizing access to powerful computational resources, making bioinformatics tools available to a broader range of users globally.

The evolving regulatory landscape and the need for compliance with data privacy standards are also shaping the bioinformatics software market. Governments and regulatory bodies across major regions are implementing stringent guidelines for the storage, sharing, and analysis of sensitive biological and patient data. This is prompting software vendors to develop solutions with enhanced security features and interoperability, ensuring compliance while facilitating seamless data exchange among stakeholders. The increasing emphasis on data standardization and integration is fostering the development of interoperable platforms that can support multi-omics analyses and cross-disciplinary research, further expanding the potential applications of bioinformatics software.

Bioinformatics in Healthcare is rapidly transforming the landscape of medical research and patient care. The integration of bioinformatics tools in healthcare settings enables the analysis of vast amounts of biological data, aiding in the identification of disease markers and the development of personalized treatment plans. With the advent of precision medicine, bioinformatics is playing a crucial role in tailoring medical treatments to individual genetic profiles, thereby improving patient outcomes. This approach not only enhances the efficacy of treatments but also reduces the risk of adverse drug reactions. As healthcare systems increasingly adopt genomic data in clinical decision-making, bioinformatics is becoming an indispensable component in the quest for more effective and personalized healthcare solutions.

From a regional perspective, North America currently dominates the bioinformatics software market, accounting for the largest share due to its advanced healthcare infrastructure, significant investments in genomics research, and the presence of leading market players. Europe follows closely, driven by strong government support for life sciences research and a growing focus on digital health initiatives. The Asia Pacific re

Global Bioinformatics market size was USD 12.76 Billion in 2022 and it is forecasted to reach USD 29.32 Billion by 2030. Bioinformatics Industry's Compound Annual Growth Rate will be 10.4% from 2023 to 2030. What are the driving factors for the Bioinformatics market?

The primary factors propelling the global bioinformatics industry are advances in genomics, rising demand for protein sequencing, and rising public-private sector investment in bioinformatics. Large volumes of data are being produced by the expanding use of next-generation sequencing (NGS) and other genomic technologies; these data must be analyzed using advanced bioinformatics tools. Furthermore, the global bioinformatics industry may benefit from the development of emerging advanced technologies. However, the bioinformatics discipline contains intricate algorithms and massive amounts of data, which can be difficult for researchers and demand a lot of processing power. What is Bioinformatics?

Bioinformatics is related to genetics and genomics, which involves the use of computer technology to store, collect, analyze, and disseminate biological information, and data, such as DNA and amino acid sequences or annotations about these sequences. Researchers and medical professionals use databases that organize and index this biological data to better understand health and disease, and in some circumstances, as a component of patient care. Through the creation of software and algorithms, bioinformatics is primarily used to extract knowledge from biological data. Bioinformatics is frequently used in the analysis of genomics, proteomics, 3D protein structure modeling, image analysis, drug creation, and many other fields.

List of bioinformatics tools and databases students used.

Snapshot img

Bioinformatics Market Size 2025-2029

The bioinformatics market size is valued to increase by USD 15.98 billion, at a CAGR of 17.4% from 2024 to 2029. Reduction in cost of genetic sequencing will drive the bioinformatics market.

Market Insights

North America dominated the market and accounted for a 43% growth during the 2025-2029.
By Application - Molecular phylogenetics segment was valued at USD 4.48 billion in 2023
By Product - Platforms segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 309.88 million 
Market Future Opportunities 2024: USD 15978.00 million
CAGR from 2024 to 2029 : 17.4%

Market Summary

The market is a dynamic and evolving field that plays a pivotal role in advancing scientific research and innovation in various industries, including healthcare, agriculture, and academia. One of the primary drivers of this market's growth is the rapid reduction in the cost of genetic sequencing, making it increasingly accessible to researchers and organizations worldwide. This affordability has led to an influx of large-scale genomic data, necessitating the development of sophisticated bioinformatics tools for Next-Generation Sequencing (NGS) data analysis. Another significant trend in the market is the shortage of trained laboratory professionals capable of handling and interpreting complex genomic data. This skills gap creates a demand for user-friendly bioinformatics software and services that can streamline data analysis and interpretation, enabling researchers to focus on scientific discovery rather than data processing. For instance, a leading pharmaceutical company could leverage bioinformatics tools to optimize its drug discovery pipeline by analyzing large genomic datasets to identify potential drug targets and predict their efficacy. By integrating these tools into its workflow, the company can reduce the time and cost associated with traditional drug discovery methods, ultimately bringing new therapies to market more efficiently. Despite its numerous benefits, the market faces challenges such as data security and privacy concerns, data standardization, and the need for interoperability between different software platforms. Addressing these challenges will require collaboration between industry stakeholders, regulatory bodies, and academic institutions to establish best practices and develop standardized protocols for data sharing and analysis.

What will be the size of the Bioinformatics Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free SampleBioinformatics, a dynamic and evolving market, is witnessing significant growth as businesses increasingly rely on high-performance computing, gene annotation, and bioinformatics software to decipher regulatory elements, gene expression regulation, and genomic variation. Machine learning algorithms, phylogenetic trees, and ontology development are integral tools for disease modeling and protein interactions. cloud computing platforms facilitate the storage and analysis of vast biological databases and sequence datas, enabling data mining techniques and statistical modeling for sequence assembly and drug discovery pipelines. Proteomic analysis, protein folding, and computational biology are crucial components of this domain, with biomedical ontologies and data integration platforms enhancing research efficiency. The integration of gene annotation and machine learning algorithms, for instance, has led to a 25% increase in accurate disease diagnosis within leading healthcare organizations. This trend underscores the importance of investing in advanced bioinformatics solutions for improved regulatory compliance, budgeting, and product strategy.

Unpacking the Bioinformatics Market Landscape

Bioinformatics, an essential discipline at the intersection of biology and computer science, continues to revolutionize the scientific landscape. Evolutionary bioinformatics, with its molecular dynamics simulation and systems biology approaches, enables a deeper understanding of biological processes, leading to improved ROI in research and development. For instance, next-generation sequencing technologies have reduced sequencing costs by a factor of ten, enabling genome-wide association studies and transcriptome sequencing on a previously unimaginable scale. In clinical bioinformatics, homology modeling techniques and protein-protein interaction analysis facilitate drug target identification, enhancing compliance with regulatory requirements. Phylogenetic analysis tools and comparative genomics studies contribute to the discovery of novel biomarkers and the development of personalized treatments. Bioimage informatics and proteomic data integration employ advanced sequence alignment algorithms and functional genomics tools to unlock new insights from complex

Bioinformatics analysis has become an integral part of research in biology. However, installation and use of scientific software can be difficult and often requires technical expert knowledge. Reasons are dependencies on certain operating systems or required third-party libraries, missing graphical user interfaces and documentation, or nonstandard input and output formats. In order to make bioinformatics software easily accessible to researchers, we here present a web-based platform. The Center for Bioinformatics Tuebingen (ZBIT) Bioinformatics Toolbox provides web-based access to a collection of bioinformatics tools developed for systems biology, protein sequence annotation, and expression data analysis. Currently, the collection encompasses software for conversion and processing of community standards SBML and BioPAX, transcription factor analysis, and analysis of microarray data from transcriptomics and proteomics studies. All tools are hosted on a customized Galaxy instance and run on a dedicated computation cluster. Users only need a web browser and an active internet connection in order to benefit from this service. The web platform is designed to facilitate the usage of the bioinformatics tools for researchers without advanced technical background. Users can combine tools for complex analyses or use predefined, customizable workflows. All results are stored persistently and reproducible. For each tool, we provide documentation, tutorials, and example data to maximize usability. The ZBIT Bioinformatics Toolbox is freely available at https://webservices.cs.uni-tuebingen.de/.

According to Cognitive Market Research, the Global Bioinformatics Services Market Size was USD XX Billion in 2023 and is set to achieve a market size of USD XX Billion by the end of 2031 growing at a CAGR of XX% from 2024 to 2031.

• The global Bioinformatics services Market will expand significantly by XX% CAGR between 2024 and 2031.

• Based on technology, Because of the growing number of platform applications and the need for improved tools for drug development, the bioinformatics platforms segment dominated the market.

• In terms of service type, The sequencing services segment held the largest share and is anticipated to grow over the coming years

• Based on application, The genomic segment dominated the bioinformatics market

• Based on End-user, academic institutes and research centers segment hold the largest share.

• Based on speciality segment, The medical bioinformatics segment holds the large share and is anticipated to expand at a substantial CAGR during the forecast period.

• The North America region accounted for the highest market share in the Global Bioinformatics Services Market. CURRENT SCENARIO OF THE BIOINFORMATICS SERVICES

Driving Factors of the Bioinformatics Services Market

Expansive uses of bioinformatics across multiple sectors is propelling the market's growth.

Several industries, such as the food, bioremediation, agriculture, forensics, and consumer industries, are also using bioinformatics services to improve the quality of their products and supply chain processes. Companies in a variety of sectors are rapidly utilizing bioinformatics services such as data integration, manipulation, lead generation, data management, in silico analysis, and advanced knowledge discovery.

• Bioinformatics Approaches in Food Sciences

In order to meet the needs of food production, food processing, enhancing the quality and nutritional content of food sources, and many other areas, bioinformatics plays a significant role in forecasting and evaluating the intended and undesired impacts of microorganisms on food, genomes, and proteomics research. Furthermore, bioinformatics techniques can be applied to produce crops with high yields and resistance to disease, among other desirable qualities. Additionally, there are numerous databases with information about food, including its components, nutritional value, chemistry, and biology.

Genome Canada is proud to partner with five Institutes where there are five funding pools within this opportunity and Genome Canada is partnering on the Bioinformatics, Computational Biology and Health Data Sciences pool. (Source:https://genomecanada.ca/genome-canada-partners-with-cihr-to-launch-health-research-training-platform-2024-25/)

• Bioinformatics in agriculture

Bioinformatics is becoming more and more crucial in the gathering, storing, and processing of genomic data in the field of agricultural genomics, or agri-genomics. Generally referred to as agri-informatics, some of the various applications of bioinformatics tools and methods in agriculture focus on improving plant resistance against biotic and abiotic stressors as well as enhancing the nutritional quality in depleted soils. Beyond these uses, computer software-assisted gene discovery has enabled researchers to create focused strategies for seed quality enhancement, incorporate extra micronutrients into plants for improved human health, and create plants with phytoremediation potential.

India/UK-based Agri-Genomics startup, Piatrika Biosystems has raised $1.2 Million in a seed round led by Ankur Capital. The company is bringing sustainable seeds and agri chemicals to market faster and cheaper. The investment will be used to build a strong Product Development team, also for more profound research, and to accelerate the productionising and commercialization of MVP. (Source:https://pressroom.icrisat.org/agri-genomics-startup-piatrika-biosystems-raises-12-million-in-seed-funding-led-by-ankur-capital)

This expansion in the application areas of bioinformatics services is likely to drive the overall market growth. Bioinformatics services such as data integration, manipulation, lead discovery, data management, in silico analysis, and advanced knowledge discovery are increasingly being adopted by companies across various industries. ...

Bioinformatics in Healthcare Market Outlook

According to our latest research, the global bioinformatics in healthcare market size reached USD 12.4 billion in 2024, reflecting robust adoption across clinical, research, and pharmaceutical domains. The market is expected to expand at a CAGR of 13.2% from 2025 to 2033, reaching a projected value of USD 36.6 billion by 2033. This impressive growth trajectory is fueled by escalating investments in genomics, rising demand for personalized medicine, and the integration of advanced computational tools in healthcare. The bioinformatics in healthcare market is witnessing a paradigm shift as organizations increasingly leverage data-driven insights to accelerate drug discovery, improve diagnostics, and enhance patient outcomes.

A primary driver for the rapid expansion of the bioinformatics in healthcare market is the surging volume of biological and clinical data being generated worldwide. The proliferation of next-generation sequencing (NGS) technologies, coupled with decreasing costs of genome sequencing, has resulted in an unprecedented influx of genetic information. This wealth of data demands sophisticated bioinformatics solutions to manage, analyze, and interpret complex datasets efficiently. As a result, healthcare institutions, research centers, and pharmaceutical companies are investing heavily in advanced bioinformatics platforms and software to unlock actionable insights from vast genomic and proteomic repositories. This trend is further amplified by the growing recognition of the pivotal role bioinformatics plays in bridging the gap between raw biological data and clinical application.

Another significant growth factor is the expanding application of bioinformatics in personalized medicine and targeted therapeutics. With the healthcare industry shifting towards precision medicine, there is an urgent need for tools that can integrate and analyze multi-omics data—spanning genomics, transcriptomics, proteomics, and metabolomics. Bioinformatics enables the identification of disease biomarkers, prediction of drug responses, and customization of treatment regimens based on individual patient profiles. This has not only improved patient outcomes but has also optimized healthcare resource utilization. The increasing prevalence of chronic diseases, rising cancer incidence, and the demand for tailored therapies are propelling the adoption of bioinformatics in clinical diagnostics and drug development, thus driving overall market growth.

Strategic collaborations and investments by government agencies, academic institutions, and private enterprises are further catalyzing the bioinformatics in healthcare market. Initiatives such as the Human Genome Project and various national genomics programs have laid the foundation for large-scale data generation and sharing. Governments across North America, Europe, and Asia Pacific are launching funding programs to support bioinformatics infrastructure, skill development, and research. These efforts are enhancing data interoperability, standardization, and integration, thereby fostering innovation in the field. Moreover, the emergence of cloud-based bioinformatics platforms is democratizing access to computational resources, enabling smaller organizations and developing regions to participate in cutting-edge research and clinical applications.

From a regional perspective, North America continues to dominate the bioinformatics in healthcare market, accounting for the largest revenue share in 2024. This leadership position is attributed to the presence of advanced healthcare infrastructure, significant R&D investments, and a strong ecosystem of academic and commercial players. Europe follows closely, driven by robust government support and a vibrant biotech sector. Meanwhile, Asia Pacific is emerging as the fastest-growing region, fueled by expanding healthcare expenditure, increasing adoption of genomic medicine, and a burgeoning talent pool in computational biology. Latin America and the Middle East & Africa are also experiencing steady growth, supported by improving healthcare systems and international collaborations.

Solution Analysis

The bioinformatics in healthcare market is segmented by solution into software, services, and platforms, each playing a critical role in the ecosystem. Bioinformatics software forms the backbone of data analysis, enabling researchers and clinicians to process and interpret complex biologi

Bioinformatics Services Market size was valued at USD 11.1 Billion in 2023 and is projected to reach USD 3.58 Billion by 2031, growing at a CAGR of 15.06% from 2024-2031.Bioinformatics Services Market: Definition/ OverviewBioinformatics services cover a wide range of computational tools and methods for managing, analyzing, and interpreting biological data. These services enable the integration of data from domains such as genomics, proteomics, transcriptomics, and metabolomics to provide insights into biological systems. Drug discovery, customized medicine, gene sequencing, and biological data management are some of the most important applications of bioinformatics. Researchers and healthcare professionals use these services to analyze big datasets, detect disease markers, and develop tailored medicines, considerably improving the precision and efficiency of life science research.

The market is segmented into four main types: NGS, chemoinformatics, microarray data analysis, and biological data curation. NGS is the largest segment, accounting for over 50% of the market share. Chemoinformatics is the second largest segment, accounting for around 25% of the market share. Microarray data analysis and biological data curation are the two smallest segments, each accounting for less than 10% of the market share.NGS is used for a variety of applications, including genome sequencing, transcriptome analysis, and whole genome de novo assembly. Chemoinformatics is used for a variety of applications, including drug discovery, molecular modeling, and clinical trial data management. Microarray data analysis is used for a variety of applications, including gene expression analysis and DNA methylation analysis. Biological data curation is used for a variety of applications, including data integration, data annotation, and data storage. Recent developments include: In July 2023, FOXO Technologies launched its Bioinformatics Services, aiming to transform the analysis of epigenetic data. This platform accelerates breakthroughs in biology, biotechnology, and healthcare and redefines the growing field of epigenetic research. This initiative addresses the longstanding challenges in processing, analyzing, and interpreting epigenetic data..

Bioinformatics Market Outlook

The global bioinformatics market size was projected at $10.4 billion in 2023 and is anticipated to grow to $24.8 billion by 2032, with a compound annual growth rate (CAGR) of 10.2%. This rapid growth is primarily attributed to the increasing demand for bioinformatics tools in genomics and proteomics research, thereby enhancing data interpretation and analysis capabilities. Additionally, the surge in the adoption of cloud-based solutions and the increasing volume of biological data generated through research activities are key factors driving the market growth. Furthermore, the rising emphasis on precision medicine and personalized healthcare approaches plays a significant role in the expansion of this market.

One of the major growth factors driving the bioinformatics market is the vast amount of biological data being generated, necessitating advanced data analysis and management tools. The advent of next-generation sequencing technologies has revolutionized genetic research, leading to exponential data generation. Bioinformatics provides the necessary computational solutions to manage, analyze, and interpret this data efficiently. Moreover, the increasing collaboration between biological scientists and computer experts is further accelerating the development of novel bioinformatics tools, enhancing their application across various domains. This interdisciplinary approach is not only improving research outcomes but also facilitating the discovery of new biological insights.

Another significant growth driver is the rising investment in research and development in the field of genomics and proteomics. Governments and private organizations across the globe are investing heavily in life sciences research to understand complex biological processes and diseases better. These investments are expected to increase the demand for sophisticated bioinformatics tools and services. Additionally, the integration of artificial intelligence and machine learning with bioinformatics is opening new avenues for research, enabling more precise data analysis and prediction models. This technological convergence is expected to provide significant growth opportunities for the bioinformatics market during the forecast period.

The increasing prevalence of chronic diseases and the growing need for personalized medicine are also contributing to the expansion of the bioinformatics market. Personalized medicine, which tailors healthcare to individual patients, relies heavily on bioinformatics to analyze genetic information and develop targeted therapies. As healthcare systems worldwide shift towards more personalized approaches, the demand for bioinformatics solutions is expected to rise significantly. Moreover, bioinformatics plays a crucial role in drug discovery and development processes, providing insights that accelerate the identification of potential drug targets and biomarkers.

The role of Life Sciences Software in the bioinformatics market is becoming increasingly prominent as researchers and healthcare providers seek more sophisticated tools to manage and analyze complex biological data. These software solutions are essential for processing the vast amounts of data generated by modern research techniques, such as next-generation sequencing and mass spectrometry. By providing robust data management and analysis capabilities, Life Sciences Software enables researchers to gain deeper insights into genetic and proteomic information, facilitating the discovery of new therapeutic targets and the development of personalized medicine approaches. As the demand for precision medicine continues to grow, the importance of Life Sciences Software in bioinformatics is expected to rise, driving innovation and market expansion.

Regionally, North America holds the largest share of the bioinformatics market due to the presence of a well-established healthcare infrastructure and significant investments in biotechnological research. The region is home to several leading bioinformatics companies and research institutions, which are at the forefront of innovation and technological advancements. Additionally, the Asia Pacific region is expected to witness the fastest growth during the forecast period, driven by increasing government funding for genomics research and the growing adoption of bioinformatics in emerging economies like China and India. The expansion of biopharmaceutical industries and a rising focus on precision medicine in these regions are further contributing to market growth.

Pro

Modern research is increasingly data-driven and reliant on bioinformatics software. Publication is a common way of introducing new software, but not all bioinformatics tools get published. Giving there are competing tools, it is important not merely to find the appropriate software, but have a metric for judging its usefulness. Journal's impact factor has been shown to be a poor predictor of software popularity; consequently, focusing on publications in high-impact journals limits user's choices in finding useful bioinformatics tools. Free and open source software repositories on popular code sharing platforms such as GitHub provide another venue to follow the latest bioinformatics trends. The open source component of GitHub allows users to bookmark and copy repositories that are most useful to them. This Perspective aims to demonstrate the utility of GitHub “stars,” “watchers,” and “forks” (GitHub statistics) as a measure of software impact. We compiled lists of impactful bioinformatics software and analyzed commonly used impact metrics and GitHub statistics of 50 genomics-oriented bioinformatics tools. We present examples of community-selected best bioinformatics resources and show that GitHub statistics are distinct from the journal's impact factor (JIF), citation counts, and alternative metrics (Altmetrics, CiteScore) in capturing the level of community attention. We suggest the use of GitHub statistics as an unbiased measure of the usability of bioinformatics software complementing the traditional impact metrics.

This dataset includes all raw Miseq high-throughput sequencing data, bioinformatic pipeline and R codes that were used in the publication "Liu M, Baker SC, Burridge CP, Jordan GJ, Clarke LJ (2020) DNA metabarcoding captures subtle differences in forest beetle communities following disturbance. Restoration Ecology. 28:1475-1484. DOI:10.1111/rec.13236."

Miseq_16S.zip - Miseq sequencing dataset for gene marker 16S, including 48 fastq files for 24 beetle bulk samples; Miseq_CO1.zip -Miseq sequencing dataset for gene marker CO1, including 46 fastq files for 23 beetle bulk samples (one sample failed to be sequenced); nfp4MBC.nf - A nextflow bioinformatic script to process Miseq datasets; nextflow.config - A configuratioin file needed when using nfp4MBC.nf; adapters_16S.zip - Adapters used to tag each of 24 beetle bulk samples for 16S, also used to process 16S Miseq dataset when using nfp4MBC.nf; adapters_CO1.zip - Adapters used to tag each of 24 beetle bulk samples for CO1, also used to process CO1 Miseq dataset when using nfp4MBC.nf; rMBC.Rmd - R markdown codes for community analyses; rMBC.zip - Datasets used in rMBC.Rmd. COI_ZOTUs_176.fasta - DNA sequences of 176 COI ZOTUs. 16S_ZOTUs_156 -DNA sequences of 156 16S ZOTUs.

This dataset was developed to create a census of sufficiently documented molecular biology databases to answer several preliminary research questions. Articles published in the annual Nucleic Acids Research (NAR) “Database Issues” were used to identify a population of databases for study. Namely, the questions addressed herein include: 1) what is the historical rate of database proliferation versus rate of database attrition?, 2) to what extent do citations indicate persistence?, and 3) are databases under active maintenance and does evidence of maintenance likewise correlate to citation? An overarching goal of this study is to provide the ability to identify subsets of databases for further analysis, both as presented within this study and through subsequent use of this openly released dataset.

Bioinformatics Platforms Market Outlook

According to our latest research, the global bioinformatics platforms market size reached USD 8.9 billion in 2024, driven by increasing adoption of advanced computational tools in life sciences and healthcare. The market is expected to register a robust CAGR of 13.2% from 2025 to 2033, projecting a significant expansion to USD 26.1 billion by 2033. This growth trajectory is primarily fueled by the surging integration of bioinformatics in genomics, proteomics, and drug discovery, as well as the rising demand for precision medicine and personalized healthcare solutions. The bioinformatics platforms market continues to evolve rapidly as technological advancements and the explosion of biological data are reshaping research and clinical practices worldwide.

The accelerating adoption of next-generation sequencing (NGS) technologies is a major growth driver for the bioinformatics platforms market. With the cost of sequencing genomes declining dramatically over the past decade, research institutions, pharmaceutical companies, and clinical laboratories are generating massive volumes of genomic data. The need to process, analyze, and interpret this data efficiently has led to a significant surge in demand for robust bioinformatics platforms. These platforms are increasingly being leveraged to streamline workflows, enable high-throughput data analysis, and facilitate the identification of novel biomarkers, drug targets, and disease mechanisms. The integration of artificial intelligence and machine learning algorithms into bioinformatics tools further enhances their analytical capabilities, allowing researchers to uncover complex patterns and gain deeper insights from multidimensional datasets.

Another key factor propelling the growth of the bioinformatics platforms market is the expanding application landscape across diverse sectors such as drug discovery, clinical diagnostics, agriculture, and environmental science. In drug discovery and development, bioinformatics platforms are instrumental in accelerating target identification, lead optimization, and toxicity prediction, thereby reducing the time and cost associated with bringing new therapeutics to market. In the clinical diagnostics arena, these platforms are enabling the implementation of precision medicine by supporting the analysis of patient-specific genomic and proteomic data. Additionally, the agriculture and crop improvement segment is witnessing increased utilization of bioinformatics solutions to enhance crop yield, disease resistance, and nutritional value through genome editing and trait selection. This broadening spectrum of applications is expected to sustain strong market growth over the forecast period.

The shift towards cloud-based and web-based deployment models represents a significant market trend, offering enhanced scalability, flexibility, and cost-effectiveness for end-users. Cloud-based bioinformatics platforms are particularly attractive to small and medium-sized enterprises and academic institutions that may lack the resources to maintain extensive on-premises infrastructure. These solutions facilitate seamless collaboration, real-time data sharing, and remote access to advanced analytical tools, thereby democratizing access to cutting-edge bioinformatics capabilities. Moreover, the increasing focus on data security, regulatory compliance, and interoperability is prompting vendors to develop platforms that adhere to industry standards and ensure the confidentiality and integrity of sensitive biological data. As the market matures, partnerships and collaborations between technology providers, research organizations, and healthcare institutions are expected to drive further innovation and adoption of bioinformatics platforms globally.

From a regional perspective, North America currently dominates the bioinformatics platforms market, accounting for the largest revenue share in 2024, followed by Europe and the rapidly growing Asia Pacific region. The strong presence of leading pharmaceutical and biotechnology companies, well-established research infrastructure, and substantial investments in genomics and precision medicine initiatives are key contributors to North America's market leadership. Europe is also witnessing significant growth, driven by supportive government policies, collaborative research projects, and the increasing adoption of bioinformatics in clinical and agricultural applications. Meanwhile, the Asia Pacific region is poised for the fastest growth during the forecast period, fueled by expanding healthcar

United Kingdom Bioinformatics Services Market was valued at USD 1.2 Billion in 2024 and is projected to reach USD 4.1 Billion by 2032, growing at a CAGR of 16.8% from 2026 to 2032.According to Verified Market Research, the following drivers and trends are shaping the UK bioinformatics services market:NHS Genomic Medicine Service Expansion - The NHS's commitment to integrating genomics into routine healthcare is creating substantial demand for bioinformatics services to support whole genome sequencing programs and rare disease diagnosisAI and Machine Learning Integration - Advanced computational methods are revolutionizing data analysis capabilities, enabling faster processing of complex genomic datasets and improving accuracy of predictive models for drug discovery and personalized medicinePrecision Agriculture Growth - UK agricultural sector increasingly adopts bioinformatics services for crop improvement, livestock breeding optimization, and sustainable farming practices, particularly in response to post-Brexit food security concerns

The Bioinformatics Services Market will grow from $4.3B in 2025 to $15.7B by 2035, at a CAGR of 12.6%, driven by rising demand for biologics and biosimilars.

Clinical Bioinformatics Market Outlook

According to our latest research, the global clinical bioinformatics market size reached USD 5.9 billion in 2024, demonstrating robust growth driven by technological advancements and the rising integration of bioinformatics in clinical settings. The market is projected to expand at a CAGR of 13.2% from 2025 to 2033, with the market value forecasted to reach USD 17.2 billion by 2033. This significant growth is primarily attributed to the increasing adoption of precision medicine, the proliferation of high-throughput sequencing technologies, and the growing demand for data-driven healthcare solutions worldwide.

One of the most influential growth factors for the clinical bioinformatics market is the rising prevalence of chronic and rare diseases globally. As genomic data becomes integral to diagnosis and treatment, healthcare providers are increasingly leveraging bioinformatics platforms to decode complex biological data and personalize therapeutic interventions. The surge in cancer cases, cardiovascular diseases, and infectious diseases has necessitated the use of advanced computational tools to analyze large datasets, identify biomarkers, and develop targeted therapies. Furthermore, the ongoing shift towards value-based care models is pushing hospitals and clinics to adopt bioinformatics solutions that enhance diagnostic accuracy, reduce costs, and improve patient outcomes.

Another key driver fueling the expansion of the clinical bioinformatics market is the rapid advancement in next-generation sequencing (NGS) technologies and the decreasing cost of genome sequencing. These technological breakthroughs have democratized access to genomic data, enabling even smaller healthcare and research institutions to incorporate bioinformatics into their workflows. The integration of artificial intelligence (AI) and machine learning algorithms into bioinformatics software is further accelerating data analysis, pattern recognition, and predictive modeling. This is not only expediting the drug discovery process but also facilitating the identification of novel therapeutic targets, thereby expanding the market’s application scope across various medical specialties.

The increasing collaboration between pharmaceutical companies, biotechnology firms, and academic research institutes is also propelling the clinical bioinformatics market. Strategic partnerships are fostering the development of innovative bioinformatics platforms tailored to specific clinical applications, such as oncology, neurology, and infectious diseases. These collaborations are supported by substantial investments from both public and private sectors, aiming to bridge the gap between basic research and clinical practice. Additionally, regulatory agencies are streamlining the approval process for bioinformatics-based diagnostics and therapeutics, further encouraging market growth.

From a regional perspective, North America continues to dominate the clinical bioinformatics market owing to its advanced healthcare infrastructure, high R&D expenditure, and early adoption of cutting-edge technologies. Europe follows closely, benefiting from supportive government policies and a strong presence of research organizations. Meanwhile, the Asia Pacific region is witnessing the fastest growth, driven by increasing healthcare investments, a burgeoning patient population, and expanding genomics research initiatives. Latin America and the Middle East & Africa are also gradually embracing clinical bioinformatics, albeit at a slower pace, due to growing awareness and improving healthcare capabilities.

Component Analysis

The component segment of the clinical bioinformatics market is primarily bifurcated into software and services, each playing a pivotal role in the industry’s overall growth. Bioinformatics software encompasses a broad range of platforms and tools designed for data management, analysis, visualization, and interpretation of complex biological information. The demand for robust, user-friendly, and scalable software solutions has surged as clinicians and researchers handle increasingly large and diverse datasets. These platforms are evolving rapidly, integrating advanced analytics, AI, and machine learning capabilities to enhance data accuracy and processing speed. As precision medicine becomes mainstream, the need for customizable and interoperable software solutions is expected to intensify, further propelling this segment’s growth.

Database of curated links to molecular resources, tools and databases selected on the basis of recommendations from bioinformatics experts in the field. This resource relies on input from its community of bioinformatics users for suggestions. Starting in 2003, it has also started listing all links contained in the NAR Webserver issue. The different types of information available in this portal: * Computer Related: This category contains links to resources relating to programming languages often used in bioinformatics. Other tools of the trade, such as web development and database resources, are also included here. * Sequence Comparison: Tools and resources for the comparison of sequences including sequence similarity searching, alignment tools, and general comparative genomics resources. * DNA: This category contains links to useful resources for DNA sequence analyses such as tools for comparative sequence analysis and sequence assembly. Links to programs for sequence manipulation, primer design, and sequence retrieval and submission are also listed here. * Education: Links to information about the techniques, materials, people, places, and events of the greater bioinformatics community. Included are current news headlines, literature sources, educational material and links to bioinformatics courses and workshops. * Expression: Links to tools for predicting the expression, alternative splicing, and regulation of a gene sequence are found here. This section also contains links to databases, methods, and analysis tools for protein expression, SAGE, EST, and microarray data. * Human Genome: This section contains links to draft annotations of the human genome in addition to resources for sequence polymorphisms and genomics. Also included are links related to ethical discussions surrounding the study of the human genome. * Literature: Links to resources related to published literature, including tools to search for articles and through literature abstracts. Additional text mining resources, open access resources, and literature goldmines are also listed. * Model Organisms: Included in this category are links to resources for various model organisms ranging from mammals to microbes. These include databases and tools for genome scale analyses. * Other Molecules: Bioinformatics tools related to molecules other than DNA, RNA, and protein. This category will include resources for the bioinformatics of small molecules as well as for other biopolymers including carbohydrates and metabolites. * Protein: This category contains links to useful resources for protein sequence and structure analyses. Resources for phylogenetic analyses, prediction of protein features, and analyses of interactions are also found here. * RNA: Resources include links to sequence retrieval programs, structure prediction and visualization tools, motif search programs, and information on various functional RNAs.